Product image of Novolizer (Budesonide) supplied by GNH India

Novolizer

Active Ingredient:
Budesonide
Origin:
EU

Novolizer (Budesonide)

Budesonide, the active ingredient in Novolizer, is a corticosteroid presented as a dry‑powder inhaler for inhalation use. It reduces airway inflammation and is used for long‑term management of asthma and chronic obstructive pulmonary disease.
GNH India supplies Novolizer as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Viatris Healthcare Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Novolizer delivers budesonide to the airways, targeting inflammatory respiratory conditions.

  • Asthma: improves symptom control and reduces exacerbations.
  • Chronic obstructive pulmonary disease (COPD): decreases frequency of flare‑ups.
  • Exercise‑induced bronchoconstriction: prevents airway narrowing during physical activity.

How It Works

  • Budesonide binds to intracellular glucocorticoid receptors, altering gene transcription to suppress pro‑inflammatory cytokines, reduce eosinophil activity, and decrease mucus production, thereby diminishing airway inflammation and hyper‑responsiveness.

Side Effects

Inhaled budesonide may cause a range of local and systemic reactions.

Common Side Effects

  • Oral candidiasis: fungal infection of the mouth.
  • Hoarseness: voice changes after inhalation.
  • Throat irritation: mild discomfort or soreness.
  • Cough: transient irritation of the airway.
  • Headache: mild to moderate intensity.
  • Upper respiratory tract infection: nasopharyngitis.

Serious or Rare Side Effects

  • Adrenal suppression: reduced endogenous cortisol production.
  • Pneumonia: especially in patients with COPD.
  • Severe allergic reaction: anaphylaxis or angioedema.
  • Growth retardation in children: potential impact on height development.
  • Paradoxical bronchospasm: sudden worsening of breathing.

Precautions & Warnings

Before prescribing Novolizer, consider the following safety measures.

  • Assess infection risk: evaluate for active respiratory infections.
  • Monitor growth in children: regular height checks are recommended.
  • Avoid abrupt discontinuation: taper if long‑term systemic exposure is suspected.
  • Use mouth rinse after inhalation: reduces risk of oral candidiasis.
  • Check for hypersensitivity: discontinue if allergic reactions occur.
  • Store at room temperature: keep in the original pack, protect from moisture and heat.

Avoid Interactions

Budesonide may interact with other medicines; some require avoidance while others need monitoring.

Major Interactions (Avoid)

  • Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase systemic budesonide exposure.
  • Ritonavir: potent CYP3A4 inhibition leading to higher corticosteroid levels.
  • Systemic corticosteroids: additive immunosuppressive effects.
  • Live vaccines: reduced efficacy and increased infection risk.

Moderate Interactions (Monitor Closely)

  • Moderate CYP3A4 inhibitors (e.g., fluconazole): may modestly raise budesonide levels.
  • Macrolide antibiotics (e.g., erythromycin): potential increase in systemic exposure.
  • Diuretics: may enhance risk of hypokalemia when combined with systemic steroids.

Frequently Asked Questions

Novolizer is an inhaled dry‑powder device that delivers budesonide, a corticosteroid, for the long‑term management of asthma and chronic obstructive pulmonary disease (COPD) to reduce airway inflammation and prevent exacerbations.

Budesonide binds to glucocorticoid receptors inside airway cells, modulating gene expression to suppress inflammatory cytokines, reduce eosinophil activity, and limit mucus production, which together decrease airway swelling and hyper‑responsiveness.

The prescribed dose of Novolizer is determined by the treating physician based on the patient’s age, disease severity, and response to therapy. Patients should follow the specific dosing instructions provided by their healthcare professional.

Budesonide is classified as a Category C drug in pregnancy; it should only be used if the potential benefit justifies the potential risk to the fetus. Limited data are available for breastfeeding, and a clinician should evaluate the risk‑benefit ratio before use.

Enquiries are submitted via the product page at gnhindia.com, where you specify the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Novolizer delivers budesonide, which has a high topical potency and low systemic bioavailability compared with some alternatives such as fluticasone. Its dry‑powder formulation offers breath‑actuated delivery without a propellant, which can improve patient adherence.

Novolizer should be stored at room temperature, below 25 °C, in its original packaging. Keep the device away from moisture and direct heat, and protect the inhaler from physical damage.

Novolizer is a breath‑actuated dry‑powder inhaler. The patient exhales fully, places the mouthpiece in the mouth, seals lips, and inhales rapidly and deeply to ensure the powder reaches the lungs. After each dose, the device should be closed to protect the powder.

Serious risks include adrenal suppression, pneumonia (especially in COPD patients), severe allergic reactions such as anaphylaxis, growth retardation in children, and paradoxical bronchospasm. Patients should be monitored for these events and advised to seek medical attention if they occur.

Novolizer is contraindicated in individuals with a known hypersensitivity to budesonide or any component of the inhaler. It should also be avoided in patients with untreated fungal, bacterial, or viral infections of the respiratory tract until the infection is resolved.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Budesonide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT